Brentuximab Vedotin

Introduction

Brentuximab Vedotin is a prescription medicine used in the treatment of certain types of cancer, including Hodgkin lymphoma and systemic anaplastic large cell lymphoma. It is an antibody-drug conjugate designed to target and destroy cancer cells while minimizing damage to healthy cells. Brentuximab Vedotin is generally prescribed by oncologists and administered in a hospital or clinic setting. The medicine offers a targeted approach to cancer treatment, which may improve patient outcomes and reduce side effects compared to traditional chemotherapy.

Uses of Brentuximab Vedotin

• Treatment of Hodgkin lymphoma
• Treatment of systemic anaplastic large cell lymphoma (sALCL)
• Used in relapsed or refractory cancer cases
• Post-transplant consolidation therapy

How Brentuximab Vedotin works

Brentuximab Vedotin works by combining an antibody that targets the CD30 protein on cancer cells with a chemotherapy drug. Once the antibody binds to CD30, the drug is delivered directly inside the cancer cell, where it disrupts the microtubule network, leading to cell death. This targeted delivery helps reduce damage to normal, healthy cells.

Benefits of Brentuximab Vedotin

• Targets cancer cells specifically
• Minimizes damage to healthy cells
• Effective for relapsed or refractory cases
• Can be used as part of combination therapy

How to take Brentuximab Vedotin

Brentuximab Vedotin is given as an intravenous (IV) infusion, usually once every three weeks, under the supervision of a healthcare professional. The dosage depends on body weight, medical condition, and response to treatment. Do not self-administer this medicine. Your doctor will monitor you for side effects and adjust the dose if necessary.

Type of Dosage Available

• Injection (Intravenous infusion)
• Single-use vial for reconstitution

Side effects of Brentuximab Vedotin

• Nausea
• Fatigue
• Peripheral neuropathy (numbness or tingling in hands and feet)
• Fever
• Diarrhea
• Severe allergic reactions (rare)

Safety advice

• Not recommended during pregnancy or breastfeeding
• Use with caution in patients with liver or kidney problems
• Regular blood tests are needed during treatment
• Inform your doctor about all other medications you are taking

Frequently Asked Questions (FAQs)

Q: What is Brentuximab Vedotin used for?

A: It is used for the treatment of Hodgkin lymphoma and systemic anaplastic large cell lymphoma, especially in relapsed or refractory cases.

Q: How is Brentuximab Vedotin given?

A: It is given as an intravenous infusion in a hospital or clinic, usually once every three weeks.

Q: Can I take Brentuximab Vedotin during pregnancy?

A: No, it is not recommended during pregnancy as it may harm the unborn baby. Use effective birth control during treatment.

Q: What should I do if I miss a dose?

A: Contact your doctor immediately to reschedule the infusion. Do not try to take a double dose.